Patients Rising is a Washington, DC-based non-profit organization with a very specific mission: we advocate for access to vital therapies and services for all patients with life-threatening and chronic diseases.  That is why Patients Rising is committed to bringing forward the patient voice as...
Washington, DC – September 29, 2016 – The Alliance for the Adoption of Innovations in Medicine (Aimed Alliance)—urged the Institute for Clinical and Economic Review (ICER) to consider patient-defined value of non-small cell lung cancer (NCSLC) treatments and the discrimination that can result...
For years, PhRMA has supported policies that ensure health care decisions are grounded in the best available evidence. In our policy solutions for delivering innovative treatments to patients released earlier this year, we reiterate our belief that well-designed tools for value assessment can ease...
The following statement was issued by the Bonnie J. Addario Lung Cancer Foundation (ALCF) in response to the scoping document evaluating certain lung cancer drugs released by the Institute for Clinical Economic Review (ICER): In concert with our partners in the Lung Cancer Action Network (...
CLSA identifies several areas of concern and suggestions for improvement regarding the cost and value of new drugs and medical technologies SAN FRANCISCO & WASHINGTON, D.C.-- California Life Sciences Association (CLSA), the nation’s largest statewide public policy and business...

Pages